Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Gilead Sciences, Inc. (NASDAQ:GILD) and Abbott Laboratories (NYSE:ABT) both return cash to shareholders through dividends, ...

Focus Wealth Management released its Q2 2026 investor letter. You can download a copy of the letter here. The fund highlighted a period of strong equity market gains as the S&P 500 surged ~17% ...

Abbott Laboratories receives a Hold rating, as its current valuation reflects much of its business quality and future growth ...

Valued at a market cap of $194.6 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells a wide range of healthcare products across various ...

Follow Abbott Laboratories as investors assess medical devices and diagnostics, the current catalyst, execution risks and the company evidence that may shape its next market move.

Check out the latest Abbott Laboratories (ABT) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

These two high-quality dividend payers have had very different fortunes recently.

Will Abbott, which is expanding into comprehensive healthcare centered on FreeStyle Libre, or DexCom, which is aiming for high growth and high profitability as a CGM specialist, prevail?]Record Date: ...

Good morning and thank you for standing by. Welcome to Abbott’s Fourth Quarter 2014 Earnings conference call. All participants will be able to listen only until the question and answer portion of this ...